{"product_id":"2025-update-in-hematology-and-medical-oncology","title":"2025 Update in Hematology and Medical Oncology","description":"\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003ch3\u003eSpecialties\u003c\/h3\u003e\n\u003cbr\u003eSpecialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology\u003cbr\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003cbr\u003eThe 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology, condensed into an intensive three-and-a-half-day virtual program, provides a thorough and up-to-date review of the diagnosis, staging, and management of neoplastic diseases, encompassing both solid tumors and hematologic malignancies. Lectures and discussions focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.\u003cbr\u003e\u003cbr\u003eThis course is a live virtual event designed for medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. It aims to help participants effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.\u003cbr\u003e\u003cbr\u003eParticipants will also receive access to an online syllabus featuring select PDFs of presentation slides and video recordings of the lectures.\u003cbr\u003e\u003ch3\u003eObjectives\u003c\/h3\u003e\n\u003cbr\u003eAt the conclusion of this course, attendees will be able to:\u003cbr\u003e\u003col\u003e\n\u003cli\u003eDefine state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.\u003c\/li\u003e\n\u003cli\u003eDiscuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice\u003c\/li\u003e\n\u003cli\u003ePrepare for ABIM examinations in medical oncology and hematology.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eSchedule\u003c\/h3\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eFriday, March 7, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003e\u003cstrong\u003eRelevant Financial Relationships\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e9:00AM - 9:10AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eColon Cancer\u003c\/strong\u003e\u003cbr\u003e9:15AM - 10:00AM\u003cbr\u003eLeonard B Saltz, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMelanoma\u003c\/strong\u003e\u003cbr\u003e10:00AM - 10:45AM\u003cbr\u003eMichael Postow, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eKidney Cancer\u003c\/strong\u003e\u003cbr\u003e10:45AM - 11:30AM\u003cbr\u003eRobert Motzer, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eProstate Cancer\u003c\/strong\u003e\u003cbr\u003e11:30AM - 12:15PM\u003cbr\u003eSusan Slovin, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMesothelioma\u003c\/strong\u003e\u003cbr\u003e12:15PM - 1:00PM\u003cbr\u003eMichael Offin, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUrothelial Cancer\u003c\/strong\u003e\u003cbr\u003e1:15PM - 2:00PM\u003cbr\u003eGopakumar Iyer, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTestis Cancer\u003c\/strong\u003e\u003cbr\u003e2:00PM - 2:45PM\u003cbr\u003eDarren Feldman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUterine, Cervix, and Other Gynecologic Cancers\u003c\/strong\u003e\u003cbr\u003e2:45PM - 3:30PM\u003cbr\u003eCarol Aghajanian, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOvarian Cancer\u003c\/strong\u003e\u003cbr\u003e3:45PM - 4:30PM\u003cbr\u003eRachel Grisham, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBreast Cancer Surgery\u003c\/strong\u003e\u003cbr\u003e4:30PM - 5:00PM\u003cbr\u003eAnita Mamtani, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBreast Cancer Radiation Therapy\u003c\/strong\u003e\u003cbr\u003e5:00PM - 5:30PM\u003cbr\u003eLior Braunstein, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHereditary Cancer Genetics\u003c\/strong\u003e\u003cbr\u003e5:30PM - 6:00PM\u003cbr\u003eZsofia Stadler, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eSaturday, March 8, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSmall Cell Lung Cancer\u003c\/strong\u003e\u003cbr\u003e7:00AM - 7:30AM\u003cbr\u003eAlissa Cooper, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHER2-Positive Breast Cancer\u003c\/strong\u003e\u003cbr\u003e7:30AM - 8:20AM\u003cbr\u003eJoshua Drago, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTriple-Negative Breast Cancer\u003c\/strong\u003e\u003cbr\u003e8:20AM - 9:10AM\u003cbr\u003eRachel Sanford, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHormone Receptor-Positive Breast Cancer\u003c\/strong\u003e\u003cbr\u003e9:10AM - 10:00AM\u003cbr\u003eDevika Gajria, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCarcinoma of Unknown Primary\u003c\/strong\u003e\u003cbr\u003e10:00AM - 10:30AM\u003cbr\u003eAnna Mary Varghese, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHepatocellular Cancer and Cholangiocarcinoma\u003c\/strong\u003e\u003cbr\u003e10:45AM - 11:30AM\u003cbr\u003eGhassan K Abou-Alfa, MD, JD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePancreatic and Neuroendocrine Cancers\u003c\/strong\u003e\u003cbr\u003e11:30AM - 12:15PM\u003cbr\u003eEileen M O'Reilly, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNon-Small Cell Lung Cancer\u003c\/strong\u003e\u003cbr\u003e1:00PM - 2:00PM\u003cbr\u003eGregory Riely, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHead and Neck, Thyroid, and Non-Melanoma Skin Cancers\u003c\/strong\u003e\u003cbr\u003e2:00PM - 3:00PM\u003cbr\u003eLara Dunn, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnal and Rectal Cancers\u003c\/strong\u003e\u003cbr\u003e3:00PM - 3:45PM\u003cbr\u003eAndrea Cercek, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEsophageal and Gastric Cancers\u003c\/strong\u003e\u003cbr\u003e3:45PM - 4:30PM\u003cbr\u003eDavid Ilson, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCentral Nervous System Tumors\u003c\/strong\u003e\u003cbr\u003e4:30PM - 5:00PM\u003cbr\u003eThomas Kaley, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSarcoma\u003c\/strong\u003e\u003cbr\u003e5:00PM - 5:45PM\u003cbr\u003eRobert G Maki, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eInfectious Disease\u003c\/strong\u003e\u003cbr\u003e5:45PM - 6:15PM\u003cbr\u003eSusan Seo, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eSunday, March 9, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePharmacology I_II PT. 1\u003c\/strong\u003e\u003cbr\u003e7:00AM - 9:00AM\u003cbr\u003eMrinal Gounder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePharmacology I_II PT. 2\u003c\/strong\u003e\u003cbr\u003e7:00AM - 7:10AM\u003cbr\u003eMrinal Gounder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAcute Myeloid Leukemia\u003c\/strong\u003e\u003cbr\u003e9:10AM - 9:50AM\u003cbr\u003eEytan Stein, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLow-Grade Non-Hodgkin Lymphoma\u003c\/strong\u003e\u003cbr\u003e9:50AM - 10:30AM\u003cbr\u003eAndrew D Zelenetz, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eChronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma\u003c\/strong\u003e\u003cbr\u003e10:30AM - 11:10AM\u003cbr\u003eMeghan C Thompson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDiffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma\u003c\/strong\u003e\u003cbr\u003e11:10AM - 12:10PM\u003cbr\u003ePaul A Hamlin, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHodgkin Lymphoma _ T Cell\u003c\/strong\u003e\u003cbr\u003e12:40PM - 1:40PM\u003cbr\u003eAlison Moskowitz, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAuto _Allo\u003c\/strong\u003e\u003cbr\u003e1:40PM - 2:20PM\u003cbr\u003eGunjan Shah , MD, MS\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCAR T Cells\u003c\/strong\u003e\u003cbr\u003e2:20PM - 2:50PM\u003cbr\u003eCraig Sauter, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAcute Lymphocytic Leukemia\u003c\/strong\u003e\u003cbr\u003e2:50PM - 3:20PM\u003cbr\u003eMark B Geyer , MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMyeloproliferative Neoplasms\u003c\/strong\u003e\u003cbr\u003e3:40PM - 4:05PM\u003cbr\u003eRaajit Rampal, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMyelodysplastic\u003c\/strong\u003e\u003cbr\u003e4:05PM - 4:30PM\u003cbr\u003eAaron D Goldberg, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eChronic Myelogenous Leukemia\u003c\/strong\u003e\u003cbr\u003e4:30PM - 5:00PM\u003cbr\u003eMichael Mauro, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMyeloma _Amyloid\u003c\/strong\u003e\u003cbr\u003e5:00PM - 6:00PM\u003cbr\u003eMalin Hultcrantz, MD, PhD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eMonday, March 10, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eApproach to the Bleeding Patient\u003c\/strong\u003e\u003cbr\u003e8:05AM - 8:50AM\u003cbr\u003eAvi Leader, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThrombotic Disorders\u003c\/strong\u003e\u003cbr\u003e8:50AM - 9:50AM\u003cbr\u003eJeffrey Zwicker, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAntithrombotic and Antiplatelet Therapy\u003c\/strong\u003e\u003cbr\u003e9:50AM - 10:30AM\u003cbr\u003eSimon Mantha, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThrombocytopenia and ITP\u003c\/strong\u003e\u003cbr\u003e10:30AM - 11:00AM\u003cbr\u003eCy R Wilkins, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSickle Cell Disease, Thalassemia\u003c\/strong\u003e\u003cbr\u003e11:00AM - 12:00PM\u003cbr\u003eSusanna Curtis, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHemolytic Anemia\u003c\/strong\u003e\u003cbr\u003e12:30PM - 1:05PM\u003cbr\u003eGerald Soff, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClinical Indications for Use of Blood Products and Associated Risks\u003c\/strong\u003e\u003cbr\u003e1:05PM - 2:00PM\u003cbr\u003eP. Dayand D Borge Jr., MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTransfusion Reactions\u003c\/strong\u003e\u003cbr\u003e2:00PM - 2:45PM\u003cbr\u003eGrace E Linder, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954487922786,"sku":"MED-AMB04365","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/2025-Update-in-Hematology-and-Medical-Oncology.jpg?v=1779377777","url":"https:\/\/meducourse.com\/products\/2025-update-in-hematology-and-medical-oncology","provider":"Meducourse","version":"1.0","type":"link"}